Silence Therapeutics Plc (SLNCF)
6.526
+0.17
(+2.70%)
USD |
OTCM |
Nov 12, 16:00
Silence Therapeutics EPS Diluted (Quarterly) : 0.00 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.00 |
| June 30, 2026 | -0.0866 |
| March 31, 2026 | -0.1055 |
| December 31, 2025 | -0.0831 |
| September 30, 2025 | -0.1479 |
| June 30, 2025 | -0.193 |
| March 31, 2025 | -0.2014 |
| September 30, 2024 | -0.2487 |
| June 30, 2024 | -0.14 |
| Date | Value |
|---|---|
| March 31, 2024 | -0.0175 |
| December 31, 2023 | -0.1504 |
| September 30, 2023 | -0.0933 |
| June 30, 2023 | -0.12 |
| March 31, 2023 | -0.1149 |
| December 31, 2022 | -0.1497 |
| September 30, 2022 | -0.0846 |
| June 30, 2022 | -0.1668 |
| March 31, 2022 | -0.1148 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -1.007 |
| Mereo BioPharma Group Plc | -0.0364 |
| Compass Pathways Plc | -0.3112 |
| HemoGenyx Pharmaceuticals Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Enterprise Value | 853.12M |
| Gross Profit Margin (Quarterly) | 72.27% |
| Profit Margin (Quarterly) | -3.54K% |
| Earnings Yield | -4.22% |
| Normalized Earnings Yield | -6.483 |